Event Pass Information Event Pass TypePriceQuantity Standard Rate (€2,499 + VAT = €2,691.42) IMPORTANT NOTICE: To qualify for Academic Pricing, all registrants are required to hold a current Academic position and provide a confirmation letter of role from the academic institution if requested. Please use your academic title and the academic institution name in your registration. Cancellation PolicyWorldwide Terms and Conditions Kisaco Research Terms and Conditions Please read the information listed below as each booking is subject to Kisaco Research Ltd standard terms and conditions. Payment Terms Upon completion and return of the registration form, full payment is required no later than 5 business days from the date of invoice. Payment of invoices by means other than by credit card, or purchase order (Kisaco Research LLC and UK government bodies only) will be subject to a £49 (plus VAT) per delegate processing fee. Payment must be received prior to the conference date. We reserve the right to refuse admission to the conference if payment has not been received. Kisaco Research Cancellation, Postponement and Substitution Policy You may substitute delegates at any time by providing at least 14 days’ notice to Kisaco Research. For any cancellations received in writing not less than eight (8) days prior to the conference, you will receive a 90% credit to be used at another Kisaco Research conference, which must occur within 14 months from the date of issuance of such credit. An administration fee of 10% of the contract fee will be retained by Kisaco Research for all permitted cancellations. No credit will be issued for any cancellations occurring within seven (7) days (inclusive) of the conference. In the event that Kisaco Research cancels an event for any reason, you will receive a credit for 100% of the contract fee paid. You may use this credit for another Kisaco Research event to be mutually agreed with Kisaco Research, which must occur within 14 months from the date of cancellation. In the event that Kisaco Research postpones an event for any reason and the delegate is unable or unwilling to attend in on the rescheduled date, you will receive a credit for 100% of the contract fee paid. You may use this credit for another Kisaco Research event to be mutually agreed with Kisaco Research, which must occur within 14 months from the date of postponement. Except as specified above, no credits will be issued for cancellations. There are no refunds given under any circumstances. Kisaco Research is not responsible for any loss or damage as a result of a substitution, alteration or cancellation/postponement of an event. Kisaco Research shall assume no liability whatsoever in the event this conference is cancelled, rescheduled or postponed due to a fortuitous event, Act of God, unforeseen occurrence or any other event that renders performance of this conference impracticable, illegal or impossible. For purposes of this clause, a fortuitous event shall include, but not be limited to: war, fire, labour strike, extreme weather or other emergency. Please note that while speakers and topics were confirmed at the time of publishing, circumstances beyond the control of the organisers may require substitutions, alterations or cancellations of the speakers and/or topics. As such, Kisaco Research reserves the right to alter or modify the advertised speakers and/or topics if necessary without any liability to you whatsoever. Any substitutions or alterations will be updated on our web page as soon as possible. Discounts All ‘Early Bird’ Discounts require payment at time of registration and before the cut-off date in order to receive any discount. Any discounts offered whether by Kisaco Research(including team discounts) must also require payment at the time of registration. All discount offers cannot be combined with any other offer unless otherwise noted. €2,691.42 EUR 0 1 2 3 4 5 6 7 8 9 10 11 Event Details Progressing translation of protein degradation probes into safe, effective therapeutics. The European Protein Degradation Congress will bring together leading industry players within big pharma and biotech along with expert academics in the ubiquitin space - providing an open forum and facilitate the sharing of in vitro and in vivo data, as well as build a deeper mechanistic understanding of the ubiquitin pathways and techniques to make the ‘undruggable’ druggable. Expect to hear strategies to overcome the structural biology, pharmacology and chemistry obstacles associated with the discovery and development of these bi-functional and single entity molecules.